Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Neuronetics Forecasts Q3 revenue of $18.5M-$19.5M Versus Consensus Of $20.115M, With 2024 Sales Of $78M-$80M Compared To Consensus Of $79.15M

Author: Benzinga Newsdesk | August 12, 2024 07:18am

For the full year 2024, the Company expects total operating expenses to be between $78.0 million and $80.0 million.

Posted In: STIM